Tranexamic Acid In Sodium Chloride Injection, Solution
Product Images NDC 51754-0108

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tranexamic Acid In Sodium Chloride (NDC 51754-0108). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exela Pharma Sciences, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

Structural Formula (Image 01)
Chemical structure diagram of tranexamic acid showing the molecular arrangement with an amino group and a carboxylic acid group attached to a cyclohexane ring.*
FDA Label Image

Exela Logo (Image 02)

FDA Label Image

Iv Bag Label (Image 03)

Iv Bag Label (Image 03)
Label for Tranexamic Acid in 0.7% Sodium Chloride Injection, 10 mg/mL, intravenous infusion solution in a 100 mL single-dose container. Manufactured and distributed by Exela Pharma Sciences, LLC, the label includes lot and expiration date fields, dosage form, active ingredient strength, usage instructions to discard unused portion, cautions about solution clarity and medication addition, storage conditions, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.